Diabetes mellitus and risk of colorectal cancer: a meta-analysis.

By S. Larsson, Nicola Orsini, A. Wolk. Journal of the National Cancer Institute, 2005

1,046 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/8b97b7b50d3fb027f4c0e57e75b54dae630f0458

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

D. Leroith

In Oncology

Citations in the corpus

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes (2009, background): “Diabetes carries an increased risk of breast [16], colon [4] and pancreatic [17] cancer, each of which features among the top five causes of cancer mortality in the USA [2].”
Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies (2013, background): “Moreover, there is an increased risk of CRC development associated with type 2 diabetes [62].”
Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. (2015, background): “esophageal cancer in men (83); breast and endometrial cancer in women (58, 108); and kidney and colorectal cancer in men and women (109, 110) have been reported.”
Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies. (2008, background): “The assignment of GI values to Downloaded from https://academic.oup.com/ajcn/article-abstract/87/3/627/4633329 by guest on 24 April 2018 TABLE 3 Rate ratios (and 95% CIs) for the comparison of the highest with the lowest quantile for developing chronic disease because of increasing glycemic index or”
Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events (2007, background): “Recently, there has been speculation as to a possible etiologic role of insulin resistance or, hyperinsulinemia, in colorectal cancer (57, 58), a hypothesis that has received some support from studies demonstrating a positive association between glucose levels and diabetes with the malignancy (7).”
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue (2009, background): “In addition, diabetes mellitus, a disease characterized by insulin resistance, is associated with an increased risk of breast, colorectal, pancreatic, and bladder cancer (58-61).”
American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 (2009, background): “In a systematic review and meta-analysis of 15 studies, Larsson (”
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study (2009, result): “An OR of 1.82 (95% CI 1.66 to 1.89) has been reported for pancreatic cancer, and an RR of 2.10 (95% CI 1.75 to 2.53) has been calculated for endometrial cancer [6, 7 ]. Similar results have been reported for other cancer entities.”
Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. (2007, background): “Epidemiologic evidence indicates that high circulating concentrations of insulin and C-peptide (a marker of pancreatic insulin secretion) (24, 47–51) as well as diabetes (52) are associated with a greater risk of colorectal cancer.”